[go: up one dir, main page]

DK1221438T3 - Salts of Amlodipine Mesylate - Google Patents

Salts of Amlodipine Mesylate

Info

Publication number
DK1221438T3
DK1221438T3 DK01129690T DK01129690T DK1221438T3 DK 1221438 T3 DK1221438 T3 DK 1221438T3 DK 01129690 T DK01129690 T DK 01129690T DK 01129690 T DK01129690 T DK 01129690T DK 1221438 T3 DK1221438 T3 DK 1221438T3
Authority
DK
Denmark
Prior art keywords
weak
degrees
modification
amlodipine mesylate
salts
Prior art date
Application number
DK01129690T
Other languages
Danish (da)
Inventor
Ralf Dr Hoss
Michael Oelting
Beat W Dr Mueller
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Application granted granted Critical
Publication of DK1221438T3 publication Critical patent/DK1221438T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Two crystal modifications of amlodipine mesylate are new. Two new crystal modifications of amlodipine mesylate are: (a) modification A of m.pt. 184 plus or minus 4 degrees C and peaks at 6.6 (very strong), 10.2 (weak), 11.0 (very strong), 14.7 (weak) and 15.9 (average) degrees 2 Theta in the powder X-ray diagram; and (b) modification B with m.pt. 145 3 degrees C and peaks at 3.8 (very weak), 7.5 (average), 11.3 (very strong), 12.5 (weak), 14.4 (weak) and 15.1 (weak) degrees 2 Theta in the powder X-ray diagram. Independent claims are also included for the preparation of anhydrous modification A and of modification B.
DK01129690T 2001-01-09 2001-12-13 Salts of Amlodipine Mesylate DK1221438T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH222001 2001-01-09

Publications (1)

Publication Number Publication Date
DK1221438T3 true DK1221438T3 (en) 2007-06-18

Family

ID=4228649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01129690T DK1221438T3 (en) 2001-01-09 2001-12-13 Salts of Amlodipine Mesylate

Country Status (4)

Country Link
EP (1) EP1221438B1 (en)
AT (1) ATE356806T1 (en)
DE (1) DE50112189D1 (en)
DK (1) DK1221438T3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100538641B1 (en) * 2002-07-30 2005-12-22 씨제이 주식회사 An organic acid salt of amlodipine
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
DE112004000712T5 (en) * 2003-04-25 2006-10-19 Cipla Ltd. Process for the preparation of amlodipine mesylate monohydrate
WO2021114012A1 (en) * 2019-12-09 2021-06-17 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, preparation method therefor and use thereof
CN112538044B (en) * 2019-12-09 2021-08-13 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
PL189666B1 (en) * 1998-04-09 2005-09-30 Adamed Sp Z Oo Method of obtaining amlopidine benzenosulphonate
CN1091441C (en) * 1999-12-04 2002-09-25 昆明赛诺制药有限公司 Amlo dipine mesylate and its preparation and application

Also Published As

Publication number Publication date
ATE356806T1 (en) 2007-04-15
DE50112189D1 (en) 2007-04-26
EP1221438B1 (en) 2007-03-14
EP1221438A3 (en) 2003-10-08
EP1221438A2 (en) 2002-07-10

Similar Documents

Publication Publication Date Title
AU2003240054A8 (en) Photonic switch working in momentum-divison-multiple-access (mdma) mode for microwave and optical wavelengths based upon the measurement of the spin, the orbital angular momentum and the total angular momentum of the involved photo
DK1719511T3 (en) N- [4- (4-amino-2-ethyl-1H-imidazo [4,5-c] quinolin-1-yl) butyl] methanesulfonamide, a pharmaceutical composition comprising the same, and use thereof
DE60237851D1 (en) Modified propylene polymer, composition containing the same and their use
CY2012032I1 (en) 1,2-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF
DK1541332T3 (en) Machine for making bags
DK1445249T3 (en) NEW BENSOPHENON DERIVATIVES OR SALTS THEREOF
ITRM20030521A1 (en) SUBSIDY LOCKING PROCEDURE THROUGH THE ETHER.
ES2110375T3 (en) NIMESULIDE FOR EXTERNAL USE.
ATE319684T1 (en) SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICATIONS
NO20035333D0 (en) New ligand for nicotinic acetylcholine receptors useful in therapy
DE60211576D1 (en) Cassette for knife and cutting device with the same
DE60216233D1 (en) Carbolinderivate
NO20040702L (en) Combined preparations containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances and the use thereof
EE03848B1 (en) Solid herbicidal mixtures based on sulphonylureas and adjuvants, methods for their preparation and use
DK1221438T3 (en) Salts of Amlodipine Mesylate
NO20040404L (en) 2- (3,5-Bis-trifluoromethyl-phenyl) -N- [6- (1,1-dioxo-1am-bda6-thiomorpholin-4-yl) -4- (2-methyl- or 4-fluoro-2- methyl substituted) phenyl-pyridin-3-yl] -N-methyl-isobutyramine.
DE69817995D1 (en) Flexible, foldable blood bag
FR2821719B1 (en) NOVEL FUNGICIDAL COMPOSITIONS BASED ON PYRIDYLMETHYLBENZAMIDE AND PROPAMOCARB DERIVATIVES
DK1532141T3 (en) 2-Pyrrolidin-2-yl [1,3,4] oxadiazole derivatives and their use as antidepressants
DK1228858T3 (en) Method and machine for making bags comprising complementary closure profiles
IL163648A0 (en) B-ä'(2S)-4-(3,4-difluorobenzyl)morpholin-2-ylmethylü-2-ä3-'(methylsulphonyl)aminophenylüacetamide asccr3 antagonist
AU2002953286A0 (en) The beath & dixon chemical bag cutter
DK1423429T3 (en) Antibodies against caspase-8 and their preparation and use
DE60011333D1 (en) Strip printing device, strip cassette and strip printing device with this strip cassette, and strip cutting device
DK1492781T3 (en) N, N'-disubstituted piperazine compounds and their use as analgesics